Prognostic factors for worsening and improvement in multiple sclerosis using a multistate model

Area of Science:

• Neurology
• Neuroimmunology
• Clinical Research

Background:

• Early treatment initiation is crucial for improving the long-term disease trajectory in multiple sclerosis (MS).
• Quantitative evidence on factors influencing disability worsening and improvement is needed for timely treatment decisions.

Purpose of the Study:

• To develop a multistate model quantifying demographic, clinical, and imaging factors' influence on disability worsening and improvement in MS.
• To analyze these factors across the full disability spectrum measured by the Expanded Disability Status Scale (EDSS).

Main Methods:

• Utilized clinical trial data from the Novartis-Oxford MS database (~8000 patients, ~130,000 EDSS assessments).
• Employed a multistate model to simultaneously assess predictors of disability worsening and improvement.
• Included all MS phenotypes in the analysis.

Main Results:

• Increased brain volume positively correlated with disability improvement (HR 1.09-1.19).
• Higher T2 lesion volume negatively impacted improvement up to EDSS 6 (HR 0.80-0.89).
• Older age, longer time since symptom onset, and recent relapses predicted disability worsening.

Conclusions:

• Brain damage is a primary factor limiting improvement potential throughout the course of MS.
• Preserving brain integrity early in MS is critical for clinical decision-making and patient outcomes.